PAVmed's Veris Health Secures $2.5 Million in Funding
PAVmed's Veris Health Secures $2.5 Million Financing
PAVmed Inc. has successfully closed a private equity financing round raising $2.5 million through the sale of common stock in its subsidiary, Veris Health Inc. With this financing, Veris is poised to enhance its innovative cancer care solutions, reflecting a vibrant interest in its potential within the healthcare technology sector.
Details of the Financing
The financing was completed at a notably attractive pre-money valuation of approximately $35 million, with shares priced at $1.40 each. This financing comes on the heels of a previous successful raise of $2.4 million earlier, showcasing sustained investor confidence in Veris' growth trajectory. Each investor received warrants as part of the deal, allowing them to purchase additional shares at the same price of $1.40.
Purpose of the Funds
Veris intends to utilize the funds primarily to facilitate the FDA clearance process for its implantable physiological monitor, which is anticipated in the upcoming year. Such clearance is critical for introducing this innovative device into the market. Furthermore, they foresee using part of this funding for general corporate purposes, setting a solid foundation for upcoming milestones.
Statements from Leadership
Lishan Aklog, M.D., the Chairman and CEO of PAVmed, expressed enthusiasm regarding this milestone. He stated that securing this financing not only underscores the trust from investors but also puts Veris in a strong position to advance their technological endeavors. The implantable monitor is expected to significantly differentiate Veris in the crowded landscape of cancer care products.
About Veris Health
Veris Health Inc. specializes in digital health, aiming to revolutionize cancer treatment. Their flagship product, the Veris Cancer Care Platform, is an advanced digital tool designed for systematic physiological data collection and real-time monitoring of patients. This platform promotes an improved cancer care experience by integrating remote patient monitoring and offering proactive symptom management.
Insights on its Offerings
Through a comprehensive suite of connected devices, cancer patients enrolled in the Veris platform can continuously relay their physiological data to healthcare teams, enhancing their overall treatment and wellness experiences. Beyond just symptomatic reporting, the platform data helps construct longitudinal health insights, which in turn supports better decision-making for both patients and their care teams.
The Role of the Implantable Monitor
As part of their innovation lineup, Veris is working towards developing an implantable physiological monitor that will seamlessly connect with the Veris Cancer Care Platform. Set to amplify the existing tools, this monitor will independently transmit vital physiological data, offering a new dimension to patient compliance and care.
About PAVmed Inc.
PAVmed Inc. stands as a frontrunner in commercial-stage medical technology, boasting a diverse arsenal of products spanning medical devices and diagnostics. Besides Veris, their portfolio also includes Lucid Diagnostics, which is making waves with its EsoGuard and EsoCheck tools tasked with the early detection of esophageal precancer.
Engagement with Healthcare Providers
Cancer care centers exploring the Veris Health solutions can easily reach out through the company’s website for more information. They ensure that their platform is accessible and beneficial for healthcare providers aiming to improve cancer patient outcomes.
Frequently Asked Questions
What is the purpose of Veris Health's recent financing?
The financing aims to support the advancement of its implantable physiological monitor towards FDA clearance and for general operational needs.
How will the funds from the financing be utilized?
Funds will be primarily directed towards securing FDA approval for new technologies and to support ongoing operations.
What distinguishes Veris Health in the medical technology space?
Veris offers an integrated digital health platform focused on enhancing personalized cancer care through advanced remote monitoring capabilities.
What are the future plans for Veris Health's innovations?
Veris plans to expand its offerings with new implantable devices that will provide consistent monitoring and data collection for cancer care.
How can healthcare providers learn more about Veris Health?
Healthcare providers can visit Veris Health's website to get comprehensive details about their products and technologies.
About The Author
Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
